PNC Financial Services Group
ONCY

PNC Financial Services Group’s Oncolytics Biotech ONCY Stock Holding History

PNC Financial Services Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Hold
15,055
– – ﹤0.01% 3863
2025
Q4 		$13.2K Hold
15,055
– – ﹤0.01% 3847
2025
Q3 		$21.1K Hold
15,055
– – ﹤0.01% 3613
2025
Q2 		$11.6K Hold
15,055
– – ﹤0.01% 3804
2025
Q1 		$8.28K Hold
15,055
– – ﹤0.01% 3895
2024
Q4 		$13.8K Buy
+15,055
New +$15.7K ﹤0.01% 3685
2023
Q4 		– Sell
-1,196
Closed -$2.61K – 4725
2023
Q3 		$2.61K Buy
+1,196
New +$2.92K ﹤0.01% 4170

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

PNC Financial Services Group's ONCY Position: Q1 2026 in Review

PNC Financial Services Group held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 15,055 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3863.

PNC Financial Services Group first reported a position in ONCY in Q3 2023 and has held it in 7 quarters since. The position peaked at $21.1K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • PNC Financial Services Group held 15,055 shares of Oncolytics Biotech worth $12.8K as of Q1 2026.
  • PNC Financial Services Group left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3863 holding.
  • PNC Financial Services Group first reported a position in Oncolytics Biotech in Q3 2023 and has held it in 7 quarters since.
  • PNC Financial Services Group's Oncolytics Biotech position peaked at $21.1K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.